Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1467-1470

  Treanor, John J ^a   Betts, Robert F ^b   Smith, Gale E ^b   Anderson, Edwin L ^b   Hackett, Craig S ^b   Wilkinson, Bethanie E ^b   Belshe, Robert B ^b   Powers, Douglas C ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INFLUENZA VACCINE; PLACEBO; RECOMBINANT VIRUS HEMAGGLUTININ; TRIPLE VACCINE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFLUENZA VACCINATION; INJECTION PAIN; INSECT; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS NEUTRALIZATION;

EID: 0029822596     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1467     Document Type: Article

References (13)

1. LaMontagne JR, Noble GR, Quinnan GV, et al. Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis 1983;5:723-36.
2. Meiklejohn G. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982. J Infect Dis 1983;148:775-83.
3. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;270:1956-61.
4. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980;244:2547-9.
5. Quinnan GV, Schooley R, Dolin R, et al. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis 1983;5:748-57.
6. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza vaccine. J Infect Dis 1993;167:584-92.
7. Katz JM, Webster RG. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J Infect Dis 1989;160:191-8.
8. Govorkova EA, Kaverin NV, Gubareva LV, et al. Replication of influenza A viruses in a green monkey continuous cell line (Vero). J Infect Dis 1995;172:250-3.
9. Powers DC, Smith GE, Anderson EL, et al. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis 1995;171:1595-9.
10. Keitel WA, Couch RB, Cate TR, et al. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol 1994;32: 2468-73.
11. Gross PA, Quinnan GV, Weksler ME, et al. Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc 1988;36:209-12.
12. Palache AM, Beyer WEP, Luchter G, et al. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. Vaccine 1993; 11:892-908.
13. Remarque EJ, van Beek WC, Ligthart GJ, et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing home residents by the use of high-dose vaccines. Vaccine 1993;11: 649-54.